Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor is a research paper published in Brain Behavior and Immunity (2020). On theSindex it has a DataRank of 0. It has been cited 230 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: RF1 AG061047
NINDS NIH HHS
Grant: R01 NS099118
NICHD NIH HHS
Grant: R01 HD089999
National Institutes of Health
Grant: 5R01NS099118-03
Obesity-induced cerebral vascular remodeling and poor brain ischemic tolerance
National Institutes of Health
Grant: 1RF1AG061047-01A1
Carboxyl-terminal modulator protein, Aβ and brain aging
National Institutes of Health
Grant: 5R01HD089999-02
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
National Institutes of Health
FWCI
6.68
Citation Percentile
1.0%
Influential Citations
5
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Use of dexmedetomidine in patients with sepsis: a systematic review and meta-analysis of randomized-controlled trials
Additional file 1 of Use of dexmedetomidine in patients with sepsis: a systematic review and meta-analysis of randomized-controlled trials
Additional file 1 of Dexmedetomidine improves the outcomes for pediatric severe sepsis with mechanical ventilation
Additional file 1 of Dexmedetomidine improves the outcomes for pediatric severe sepsis with mechanical ventilation
Additional file 2 of Dexmedetomidine improves the outcomes for pediatric severe sepsis with mechanical ventilation
Additional file 2 of Dexmedetomidine improves the outcomes for pediatric severe sepsis with mechanical ventilation